The marked induction of apoptosis associated with CRC cell growth inhibition by SMS deletion in combination with MYC repression by JQ1 in vitro suggests that targeting both SMS and MYC signaling may be an effective strategy for CRC therapy. The gene discussed is SMS; the disease is colorectal carcinoma.